COMMUNIQUÉS West-GlobeNewswire

Skyline Medical Acquiring up to 25% Equity Stake in Helomics Corporation, a Precision Diagnostics Company
19/12/2017
MINNEAPOLIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
19/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer
19/12/2017
DOYLESTOWN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the preliminary results [...]
Galectin Therapeutics Announces $10 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Into 2019
19/12/2017
NORCROSS, Ga., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced it entered into a $10 million unsecured [...]
Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration
19/12/2017
SOUTH SAN FRANCISCO, Calif. and SHANGHAI, China, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (NASDAQ: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein [...]
SDi Announces Planned Release of 2018 Global Assessment Report
19/12/2017
LOS ANGELES, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics LLC, announced today the 2018 Global Assessment Report: The Laboratory Analytical & Life [...]
FDA Approves Spark Therapeutics’ LUXTURNA™ (voretigene neparvovec-rzyl), a One-time Gene Therapy for Patients with Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
19/12/2017
LUXTURNA is first gene therapy for a genetic disease, first and only pharmacologic treatment for an inherited retinal disease (IRD) and first adeno-associated virus (AAV) vector gene therapy approved in U.S. Children [...]
Qu Biologics invited to present research data at inaugural Crohn’s and Colitis Congress
19/12/2017
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to restore [...]
APHL Announces Newborn Screening Funding Recipients
19/12/2017
Silver Spring, MD, Dec. 19, 2017 (GLOBE NEWSWIRE) -- For Immediate Release The Association of Public Health Laboratories (APHL) is pleased to announce the recipients of the second round of New Disorders Implementation [...]
U.S. Food and Drug Administration Approves Prior Approval Supplement for Commercial Launch of Portola Pharmaceuticals’ Novel Oral Anticoagulant Bevyxxa® (betrixaban)
19/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval [...]
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer
19/12/2017
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc., (Nasdaq: APLS ) a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
TOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution Agreement
19/12/2017
BEVERLY HILLS, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
Asklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous Citrulline
19/12/2017
BALTIMORE, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special [...]
Dr. Axe Launches New Keto Diet and Fitness Plan for 2018
19/12/2017
NASHVILLE, Tenn., Dec. 19, 2017 (GLOBE NEWSWIRE) -- For those who are fed up with yo-yo weight gain, dieting, and failed attempts at living a healthier lifestyle, Doctor of Natural Medicine, Dr. Josh Axe is launching a [...]
Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test
19/12/2017
MEDFORD, N.Y., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a [...]
Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering
19/12/2017
WOBURN, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the pricing of an underwritten public offering of units for gross proceeds of $12.6 million, prior to deducting [...]
Teladoc to Participate in Upcoming Investor Conference
19/12/2017
PURCHASE, NY, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, today announced that Jason Gorevic, chief executive officer [...]
Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
19/12/2017
Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of [...]
Hemispherx Highlights Year-To-Date Progress, Outlines Key Objectives
19/12/2017
Letter to Shareholders Posted on Website Revenue Up, Burn Rate Down Dramatically; Progress Cited with FDA Discussions on Ampligen; Manufacturing Facility for FDA-Approved Alferon N Fully Repaired; Immuno-oncology Seen [...]

Pages